Shock therapy for motion sickness? new device zaps nausea away

NCT ID NCT06106256

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a wearable device that uses mild electrical stimulation on the head to reduce motion sickness during virtual reality (VR) simulations. Forty adults aged 21-55 will participate at the Mayo Clinic in Arizona. The goal is to improve the technology so people can enjoy VR without feeling sick.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Galvanic Vestibular Stimulation (GVS) device
What this could lead to
If it works, this could lead to a wearable device that eases motion sickness during VR or real-world travel.
What could go wrong
This is a small, early-stage study (40 people) testing a device in a lab setting. It may not work for everyone or translate to real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOTION SICKNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic Arizona

    Scottsdale, Arizona, 85259, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.